Andere talen SyntekaBio, Inc.

Aandelen

A226330

KR7226330009

slotkoers Korea S.E. Andere beurzen 00:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
10.600 ^KRW	-2,21%		+0,66%	-25,56%

11/04	Syntekabio presenteert innovatieve AI-technologieën voor het ontdekken van medicijnen op Bio-IT World	CI
2023	Polarisqb en Syntekabio tekenen MOU voor samenwerking op het gebied van AI en Quantum-Pored Drug Development Service	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

SyntekaBio, Inc. announced that it has received KRW 10 billion in funding from Korea Investment Partners Co. Ltd.	26/04
Syntekabio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT World	11/04
SyntekaBio, Inc. announced that it expects to receive KRW 10 billion in funding from Korea Investment Partners Co. Ltd.	28/03
Polarisqb and Syntekabio Sign MOU for Collaborative AI and Quantum-Pored Drug Development Service	31-08-23
SyntekaBio, Inc. announced that it has received KRW 10 billion in funding	28-07-23
SyntekaBio, Inc. announced that it expects to receive KRW 10 billion in funding	21-07-23
Syntekabio Announces the Launch of its Cost-Effective AI-Based Total Solution Service for Finding New Drug Candidates	03-06-23
SyntekaBio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23
Syntekabio, Inc. Launches STB Cloud Worldwide	16-12-22
Advanced AI Drug Development Platform 'DeepMatcher' 2.0 Launches Worldwide (226330.KQ)	22-09-22
Advanced AI Drug Development Platform 'DeepMatcher®' 2.0 Launches Worldwide (226330.KQ)	21-09-22
SyntekaBio, Inc. announced that it has received KRW 25 billion in funding from Shinhan Financial Investment Co., Ltd., Saneun Capital Co., Ltd., Best Investment & Securities Co., Ltd., IBK Capital Corporation,KDB Capital Corp., Shinhan Investment Corp., Investment Arm and other investors	30-11-21
SyntekaBio, Inc. announced that it expects to receive KRW 25 billion in funding from Shinhan Financial Investment Co., Ltd., Saneun Capital Co., Ltd., Best Investment & Securities Co., Ltd., IBK Capital Corporation, KDB Capital Corp., Shinhan Investment Corp., Investment Arm and other investors	25-11-21
SyntekaBio, Inc.(KOSDAQ:A226330) added to S&P Global BMI Index	21-09-20
Syntekabio Presents Nonclinical Data of Immuno-Oncologic Agent Stb-C017 At the 2020 AACR Meeting	15-05-20
SyntekaBio, Inc. has completed an IPO in the amount of KRW 19.2 billion.	12-12-19
Syntekabio Enters into Agreement with CHA Hospital	06-12-19
SyntekaBio, Inc. has filed an IPO.	26-08-19
Syntekabio, Inc. announced that it has received KRW 19.69994646 billion in funding from a group of investors	21-06-19
SyntekaBio, Inc. announced that it expects to receive KRW 19.69994646 billion in funding from a group of investors	05-06-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen SyntekaBio, Inc.

Aandelen

A226330

KR7226330009

Andere talen

Filters